Status:
UNKNOWN
Tumor Grade Determines PD-1/PDL-1 Expression
Lead Sponsor:
RWJ Barnabas Health at Jersey City Medical Center
Conditions:
Endometrial Cancer
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
Endometrial carcinoma is the most common gynecologic cancer in the western world. Two types are usually described. Type I is the endometrioid and is usually estrogen dependent. Type II is usually more...
Eligibility Criteria
Inclusion
- All ages Endometrial carcinoma Ovarian carcinoma All grades All stages All races Female patients PD-1/PDL-1 staining positive -
Exclusion
- Any cancer which is not endometrial or ovarian Cancer which do not stain positive for PD-1/PDL-1
- \-
Key Trial Info
Start Date :
August 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04528940
Start Date
August 25 2020
End Date
September 30 2021
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jersey city medical center
Jersey City, New Jersey, United States, 07302